Introduction to the BioTM special issue "Nucleic Acid Delivery: Enabling the Drugs of Tomorrow"
It is my pleasure to introduce the second issue of Bioengineering and Translational Medicine during its inaugural year. This issue focuses on one of the most pressing questions for drug delivery scientists today:
How can we engineer systems that protect the sensitive cargo that is DNA and RNA while simultaneously facilitating intracellular delivery?
With continuous advances in our understanding of the biology of nucleic acids and their role in a myriad of diseases, it is becoming increasingly evident that nucleic acid therapeutics will be a crux of the personalized medicines of tomorrow. However, we as a society will not be able to capitalize on their promise until we've developed methods for safe and effective delivery. DNA. 4 Kaushal Rege and his coworkers also report on the ability of TRAIL to kill cancer cells, in this case using aminoglycoside-derived polymer chemistry for effective DNA delivery. 5 Dave Lynn and colleagues extend the typical utility of polymer nanoparticle-mediating DNA delivery to include a controlled release element. 6 Angela Pannier and coworkers describe the identification of small molecule drugs that enhanced DNA transfection efficacy using a high throughput screening approach. 7 Stephanie Seidlits, Lonnie Shea, and their colleagues employ gene therapy to reduce neuroinflammation following spinal cord injury. 8 Specifically, they incorporate a lentiviral delivery system for interleukin-10 into a multi-channel bridge that locally delivers DNA to affected tissue following injury. Finally, Morgan
Urello, Kristi Kiick, and Millie Sullivan demonstrate the ability of a polymer nanoplex modified with collagen-mimetic peptides to deliver growth factor-encoding DNA for accelerated wound healing. 
